Prescribing of psychotropic medications to children and adolescents: quo vadis?
暂无分享,去创建一个
[1] M. Olfson,et al. National trends in the office-based treatment of children, adolescents, and adults with antipsychotics. , 2012, Archives of general psychiatry.
[2] R. Kessler,et al. Severity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement. , 2012, Archives of general psychiatry.
[3] Adrian Angold,et al. Trends in psychopathology across the adolescent years: what changes when children become adolescents, and when adolescents become adults? , 2011, Journal of child psychology and psychiatry, and allied disciplines.
[4] C. Correll,et al. Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics. , 2011, The Journal of clinical psychiatry.
[5] H. Moses,et al. Biomedical research and health advances. , 2011, The New England journal of medicine.
[6] Barbara Napolitano,et al. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. , 2009, JAMA.
[7] Olga V. Demler,et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. , 2005, Archives of general psychiatry.